Peak Wellness, Inc. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 195 Field Point Rd, Greenwich, CT 06830 Phone: 203-625-9608 Fax: 203-629-0589 |
Ana Patricia Echeverri Md Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 1/2 Dearfield Dr Ste 101, Greenwich, CT 06831 Phone: 203-994-6547 |
Greenwich Pure Medical, Llc Internal Medicine Medicare: Medicare Enrolled Practice Location: 15 Valley Dr, Greenwich, CT 06831 Phone: 203-869-2800 Fax: 203-869-2803 |
Greenwich Medical Group Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 75 Holly Hill Ln, Greenwich, CT 06830 Phone: 203-869-6960 Fax: 203-869-5103 |
Northeast Medical Group, Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 5 Perryridge Rd, Greenwich, CT 06830 Phone: 203-384-3975 |
Ambulatory Services Greenwich Hospital Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 5 Perryridge Rd, Greenwich, CT 06830 Phone: 203-863-3000 |
Glenville Medical Associates P.c Internal Medicine Medicare: Medicare Enrolled Practice Location: 7 Riversville Rd, Greenwich, CT 06831 Phone: 203-531-1808 Fax: 203-531-8326 |
Sunil Rana, M.d., P.c. Internal Medicine Medicare: Medicare Enrolled Practice Location: 49 Lake Ave Ste 2, Greenwich, CT 06830 Phone: 203-869-7704 Fax: 203-661-8596 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific Watson LIMS (laboratory information management system) offers enhanced functionality for large molecule bioanalysis in pharmaceutical and contract research organization (CRO) laboratories.
Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUSĀ® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.
Accomplishing the targets set forth in the U.N. High Level Meeting on AIDS declaration "would cost billions more per year from all sources," a New York Times editorial states.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
› Verified 3 days ago